Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure

Nephrology Dialysis Transplantation

Volumn 11, Issue 1, 1996, Pages 63-69

  Attman, P O ^a   Alaupovic, P ^b   Tavella, M ^b   Knight Gibson, C ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Apolipoproteins; Chronic renal failure; Lipids; Lipoproteins

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B; APOLIPOPROTEIN C; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPOPROTEINEMIA; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID COMPOSITION; MALE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

EID: 0030065377     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027068     Document Type: Article

References (37)

1. Attman P-O, Samuelsson O, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 1993; 21: 573-592
2. Samuelsson O, Attman P-O, Knight-Gibson C et al. Lipoprotein abnormalities without hyperlipidaerma in moderate renal insufficiency. Nephrol Dial Transplant 1994; 9: 1580-1585
3. Grützmacher P, März W, Peschke B, Gross W, Schoeppe W. Lipoproteins and apolipoproteins during the progression of chronic renal disease. Nephron 1988; 50: 103-111
4. Attman P-O, Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipo-proteinemia-Relation to renal function and dialysis. Nephron 1991; 57: 401-410
5. Attman P-O, Alaupovic P, Gustafson A. Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int 1987; 32: 368-375
6. Alaupovic P, Lee DM, McConathy WJ. Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of human plasma lipoproteins. Biochim Biophys Acta 1972; 260: 689-707
7. 1 values and apolipoprotein composition of the major lipoprotein density classes. Biochim Biophys Acta 1987; 920: 9-19
8. Kuksis A, Myher JJ, Marai L, Geher K. Determination of plasma lipid profiles by automated gas chromatography and computerized data analysis. J Chromatogr Sci 1981; 13: 423-430
9. Curry MD, McConathy WJ, Alaupovic P, Ledford JD, Popovich M. Determination of human apolipoprotein E by electroimmunoassay. Biochim Biophys Acta 1976; 439: 413-425
10. Bagdade J, Casaretto A, Albers J. Effects of chronic uremia, hemodialysis and renal transplantation on plasma lipids and lipoproteins in man. J Lab Clin Med 1976; 87: 37-48
11. Norbeck HE, Carlson LA. The uremic dyslipoproteinemia: its characteristics and relations to clinical factors. Acta Med Scand 1981; 209: 489-503
12. Joven J, Vilella E, Ahmad S, Cheung MC, Brunzell JD. Lipoprotein heterogeneity in end-stage renal disease. Kidney Int 1993; 43: 410-418
13. Parsy D, Dracon M, Cachera CA et al. Lipoprotein abnormalities in chronic haemodialysis patients. Nephrol Dial Transplant 1988; 3: 51-56
14. Alsayed N, Rebourcet R. Abnormal concentrations of CII, CIII, and E apo-lipoproteins among apolipoprotein B-containing, B-free, and A-I-containing lipoprotein particles in hemodialysis patients. Clin Chem 1991; 37: 387-393
15. Camejo G, Riera G, Lee M, Lopez F. Lipoprotein structural abnormalities in chronic renal failure with and without hemodialysis. Biomed Biochim Acta 1988; 47: 239-245
16. Senti M, Romero R, Pedrobotet J, Pelegri A, Nogues X, Rubiés-Prat J. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 1992, 41. 1394-1399
17. Nestel PJ, Fidge NH, Tan MH. Increased lipoprotein-remnant formation in chronic renal failure. J Engl J Med 1982; 307: 329-333
18. Ron D, Oren I, Aviram M, Better OS, Brook JG. Accumulation of lipoprotein remnants in patients with chronic renal failure. Atherosclerosis 1983; 46: 67-75
19. Atger V, Beyne P, Frommherz K, Roullet JB, Drücke T. Presence of apo-B48 and relative apo CII deficiency and apo CIII enrichment in uremic very-low density lipoproteins Ann Biol Clin (Paris) 1989; 47: 497-501
20. Shoji T, Nishizawa Y, Nishitam H, Yamakawa M, Morii H. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int 1992; 41: 653-1661
21. Norbeck HE, Carlson LA. Increased frequency of late pre-β lipoproteins (LPß) in isolated serum very low density lipoproteins in uraemia. Eur J Clin Invest 1980; 10. 423-426
22. Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterisation of apoA- and apoB-containing lipoprotein families. Prog Lipid Res 1991; 30: 105-138
23. Attman P-O, Tavella M, Knight-Gibson C, Samuelsson O, Alaupovic P. Apolipoprotein B-containing lipoprotein particles in progressive renal insufficiency. Contrib Nephrol 1992; 98: 11-19
24. Alaupovic P, Knight-Gibson C, Wang C-S, Downs D et al. Isolation and characterisation of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia. J Lipid Res 1991; 32: 9-19
25. Agnani G, Bard JM, Candelier L, Delattre S, Fruchart J-C, Clavey V. Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells. Arterioscler Thromb 1991; 11: 1021-1029
26. Wang CS, McConathy WJ, Kloer HU, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins: effect of apo-lippprotein C-III. J Clin Invest 1985; 75: 384-390
27. Windler E, Havel RJ. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res 1985; 26: 556-565
28. Gianturco SH, Bradley WA. Lipoprotein-mediated cellular mechanisms for atherogenesis in hypertriglyceridemia. Semin Thromb Hemost 1988; 14: 165-169
29. Tatami R, Mabuchi H, Ueda K et al. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 1981; 64: 1174-1184
30. Simons LA, Dwyer T, Simons J et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis 1987; 65: 181-189
31. Breier CH, Patsch JR, Mühlberger V, Drexel H, Knapp E, Braunsteiner H. Risk factors for coronary artery disease: a study comparing hypercholesterolaemia and hypertriglyceridaemia in angiographically characterised patients. Eur J Clin Invest 1989; 19: 419-423
32. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts - lipid and nonlipid factors. Circulation 1990; 81: 470-476
33. Phillips NR, Waters D, Havel RJ Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993; 88: 2762-2770
34. Hodis HN, Mack WJ, Azen SP et al. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild to moderate severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994; 90: 42-49
35. Samuelsson O, Aurell M, Knight-Gibson C, Alaupovic P, Attman P-O. Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron 1993; 63: 279-285
36. Alaupovic P, Knight-Gibson C, Bryant S et al. Dyslipoproteinemia of chronic renal failure is characterised by decreased levels of lipoprotein A-I:A-II and increased levels of apoC-III-containing triglyceride-rich lipoproteins. 62nd Congress of the European Atherosclerosis Society. Jerusalem. Israel, 5-9 September 1993: 36 (Abstract)
37. Cressman MD, Heyka RJ, Paganini EP, O'Neil J, Skibinski CI, Hoff HF. Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992; 86: 475-482